Morepen Laboratories Ltd. engages in the provision of business of manufacturing bulk drugs, intermediates, and medical devices; and business of formulation. It operates through the following geographical segments: the United States of America, Rest of World, and India. The company was founded by K. B. Suri on December 1, 1984 and is headquartered in Gurugram, India.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company